Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-2307
    Keywords: Breast carcinoma ; ERBB2 ; E-cadherin
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract A recent in vitro study has suggested that overexpression of ERBB2 may mediate breast tumour progression and metastasis by inhibiting the transcription of the E-cadherin (E-CD) gene. To test this hypothesis in human breast cancer in vivo, we studied the relationship between the expression of both molecules in 247 breast carcinomas immunohistochemically. Five ductal carcinomas in situ overexpressed ERBB2 and showed preserved E-CD expression. Forty-four of 226 infiltrating ductal carcinomas (19.47%) showed ERBB2 overexpression, and a statistically significant relationship was found between ERBB2 overexpression and high histological grade. E-CD expression was preserved in 111 cases (49.1%) and correlated with the histological grade. However, no significant relationship was found between ERBB2 and E-CD expression. None of the 16 infiltrating lobular carcinomas expressed ERBB2 or E-CD. These observations in different histological types of breast carcinoma strongly argue against a role for ERBB2 as a transcriptional regulator of E-CD expression in most human breast carcinomas in vivo.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-0428
    Keywords: Gliclazide ; skeletal muscle ; glucose uptake ; hindquarter perfusion ; insulin ; ATP-sensitive ; K+ channels ; diazoxide
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary We studied the effect of gliclazide, a second-generation sulphonylurea, on rat skeletal muscle glucose uptake using perfused hindquarter muscle preparations. Gliclazide at concentrations of 10 to 1000 Μg/ml increased (p〈0.05) the basal glucose uptake. The effect of gliclazide on glucose uptake was immediate and dose-dependent, reaching a plateau at a concentration of 300 Μg/ml; the half-maximal effect was obtained between 25 and 50 Μg/ml. The glucose uptake stimulated by gliclazide (300–1000 Μg/ ml) did not differ from that achieved by 10−9 mol/l insulin, and was lower (p〈0.05) than that obtained with 10−7 mol/l insulin. The combination of gliclazide (300 Μg/ml) and 10−9 mol/l insulin produced an increase in glucose uptake (7.7±0.6 Μmol · g−1 · h−1, n=8, mean±SEM) which was higher (p〈0.05) than that achieved with 10−9 mol/l insulin (5.6±0.7 Μmol · g−1 · h−1, n=11) and not different from that obtained with 10−7 mol/l insulin (9.8±1.0 Μmol · g−1 · h−1, n=11). Diazoxide (100 Μmol/l), an ATP-sensitive K+ channel opener, reversed the stimulatory effect of gliclazide (100 Μg/ml) on muscle glucose uptake from 3.1±0.4 to 0.5±0.2 Μmol · g−1 · h−1, (n=7, p〈0.001). The addition of diazoxide prior to gliclazide into the perfusion medium blocked the gliclazide-induced glucose uptake by the hindquarter muscle preparations. In conclusion, gliclazide alone has an immediate stimulatory effect on glucose uptake by skeletal muscle and together with insulin has an additive effect on muscle glucose uptake. The effect of gliclazide on muscle glucose uptake seems to be due to the inhibition of ATP-sensitive K+ channels.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...